THE SYSTEMIC ADMINISTRATION OF INTRAVENOUS MELPHALAN

[1] EFFECT OF RENAL DYSFUNCTION IN DOGS ON THE DISPOSITION AND MARROW TOXICITY OF MELPHALAN [J]. BRITISH JOURNAL OF CANCER, 1981, 43 (03) : 330 - 334

[2] ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P73

[3] ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737

[4] ANDERSON CC, 1986, CANCER CHEMOTH PHARM, V16, P170

[5] ANTMAN K, 1987, CANCER TREAT REP, V71, P119

[6] ARIEL IM, 1962, SURGERY, V51, P583

[7] HIGH-DOSE THERAPY AND AUTOLOGOUS MARROW TRANSPLANTATION AS SALVAGE TREATMENT FOR PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 871 - 877

[8] TREATMENT OF ADVANCED NEURO-BLASTOMA WITH SUPRALETHAL CHEMOTHERAPY, RADIATION, AND ALLOGENEIC OR AUTOLOGOUS MARROW RECONSTITUTION [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 609 - 616

[9] BARLOGIE B, IN PRESS BLOOD

[10] BEGLEITER A, 1979, CANCER RES, V39, P353

[1] EFFECT OF RENAL DYSFUNCTION IN DOGS ON THE DISPOSITION AND MARROW TOXICITY OF MELPHALAN [J]. BRITISH JOURNAL OF CANCER, 1981, 43 (03) : 330 - 334

[2] ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P73

[3] ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737

[4] ANDERSON CC, 1986, CANCER CHEMOTH PHARM, V16, P170

[5] ANTMAN K, 1987, CANCER TREAT REP, V71, P119

[6] ARIEL IM, 1962, SURGERY, V51, P583

[7] HIGH-DOSE THERAPY AND AUTOLOGOUS MARROW TRANSPLANTATION AS SALVAGE TREATMENT FOR PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 871 - 877

[8] TREATMENT OF ADVANCED NEURO-BLASTOMA WITH SUPRALETHAL CHEMOTHERAPY, RADIATION, AND ALLOGENEIC OR AUTOLOGOUS MARROW RECONSTITUTION [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 609 - 616

[9] BARLOGIE B, IN PRESS BLOOD

[10] BEGLEITER A, 1979, CANCER RES, V39, P353